Literature DB >> 7944953

Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein.

A K Falconar1, P R Young, M A Miles.   

Abstract

The reactions of a panel of 34 mouse monoclonal antibodies (MAbs) specific for the dengue-2 virus nonstructural-1 glycoprotein (NS1), were analysed using 174 overlapping synthetic nonameric peptides covering the entire sequence. Using this methodology, four epitopes were identified. One pair of MAbs, which defined a dengue-2/4 virus subcomplex epitope (24C: amino acids 299-309) using native NS1 proteins, showed the same reaction pattern with synthetic peptides containing the corresponding NS1 sequences of each virus serotype. One amino acid substitution, present in the sequences from the dengue-1/3 virus subcomplex abrogated almost all reaction by these MAbs. A dengue complex epitope (LX1: amino acids 111-121) was also located and peptides containing the sequences of each serotype were shown to contain only antigenically silent amino-acid substitutions. In contrast, MAbs which defined a dengue type-specific epitope (LD2: amino acids 25-33) and another dengue subcomplex epitope (24A: amino acids 61-69) failed to show the same reaction profiles using peptides of each serotype, suggesting that these determinants were partially dependent upon conformation. The LX1 epitope is a good candidate for further trials aimed at generating cross-protective immune responses to these viruses without the risk of antibody-dependent enhancement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944953     DOI: 10.1007/bf01309478

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  33 in total

1.  Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever.

Authors:  V Churdboonchart; N Bhamarapravati; S Peampramprecha; S Sirinavin
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

Review 2.  Epitopes on protein antigens: misconceptions and realities.

Authors:  W G Laver; G M Air; R G Webster; S J Smith-Gill
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

3.  Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.

Authors:  Y S Hahn; R Galler; T Hunkapiller; J M Dalrymple; J H Strauss; E G Strauss
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

4.  From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.

Authors:  W E Brandt
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

5.  Profiles of antibody-dependent enhancement of dengue virus type 2 infection.

Authors:  D M Morens; S B Halstead; N J Marchette
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

6.  The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus.

Authors:  M J Pryor; P J Wright
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

7.  The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli.

Authors:  P W Mason; M U Zügel; A R Semproni; M J Fournier; T L Mason
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

8.  The XXth century dengue pandemic: need for surveillance and research.

Authors:  S B Halstead
Journal:  World Health Stat Q       Date:  1992

9.  Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.

Authors:  J J Schlesinger; M W Brandriss; E E Walsh
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells.

Authors:  P W Mason
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

View more
  29 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Kyung Min Chung; Grant E Nybakken; Bruce S Thompson; Michael J Engle; Anantha Marri; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.

Authors:  Heather Friberg; Smita Jaiswal; Kim West; Marvin O'Ketch; Alan L Rothman; Anuja Mathew
Journal:  Viral Immunol       Date:  2012-08-30       Impact factor: 2.257

5.  Recombinant multiepitope protein for early detection of dengue infections.

Authors:  Ravulapalli Anandarao; Sathyamangalam Swaminathan; Sirimali Fernando; Asha M Jana; Navin Khanna
Journal:  Clin Vaccine Immunol       Date:  2006-01

6.  Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design.

Authors:  Andrew K I Falconar
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

7.  Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.

Authors:  Tomer Hertz; P Robert Beatty; Zachary MacMillen; Sarah S Killingbeck; Chunling Wang; Eva Harris
Journal:  J Immunol       Date:  2017-04-05       Impact factor: 5.422

8.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

9.  Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.

Authors:  Andrew K I Falconar
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

10.  Antiapoptotic but not antiviral function of human bcl-2 assists establishment of Japanese encephalitis virus persistence in cultured cells.

Authors:  C L Liao; Y L Lin; S C Shen; J Y Shen; H L Su; Y L Huang; S H Ma; Y C Sun; K P Chen; L K Chen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.